You are here

Hyphens inks MOU with A*Star's A*ccelerate

The five-year commercialisation deal covers development of products targeting eczema, acne, pigmentary disorders


SGX Catalist-listed Hyphens Pharma International Limited signed a Memorendum of Understanding (MOU) with A*Star's commercial arm A*ccelerate, previously known as Exploit Technologies, at the opening ceremony of its corporate headquarters and integrated facility in Singapore on...

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to